This page lists the SEC filings reported by M28 Capital Management LP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-02-12 | M28 Capital Management LP | Wave Life Sciences Ltd. | 7,373,413 | 6.0% | EDGAR |
| SC 13G | 2024-02-12 | M28 Capital Management LP | CURIS INC | 421,951 | 7.2% | EDGAR |
| SC 13G/A | 2023-02-10 | M28 Capital Management LP | Wave Life Sciences Ltd. | 5,903,405 | 6.8% | EDGAR |
| SC 13D/A | 2022-08-19 | M28 Capital Management LP | Adagio Therapeutics, Inc. | 9,248,250 | 8.5% | EDGAR |
| SC 13D/A | 2022-06-24 | M28 Capital Management LP | Adagio Therapeutics, Inc. | 6,398,250 | 5.8% | EDGAR |
| SC 13D/A | 2022-04-26 | M28 Capital Management LP | Adagio Therapeutics, Inc. | 6,398,250 | 5.8% | EDGAR |
| SC 13D | 2022-04-01 | M28 Capital Management LP | Adagio Therapeutics, Inc. | 6,398,250 | 5.8% | EDGAR |
| SC 13G/A | 2022-02-11 | M28 Capital Management LP | Adagio Therapeutics, Inc. | 5,665,221 | 5.1% | EDGAR |
| SC 13G | 2021-10-29 | M28 Capital Management LP | Wave Life Sciences Ltd. | 3,765,588 | 7.2% | EDGAR |
| SC 13G | 2021-10-05 | M28 Capital Management LP | Adagio Therapeutics, Inc. | 5,626,070 | 5.1% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.